ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.51469
0.00%
Bitcoin
62,824.56
-0.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Roivant Sciences Ltd (ROIVW)

  7. Roivant Sciences Ltd (ROIVW) News

ROIVW Roivant Sciences Ltd

2.75
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Roivant Sciences Ltd ROIVW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.75 10:00:00
Open Price Low Price High Price Close Price Previous Close
2.75 2.75
more quote information »

Recent News

Date Time Source Heading
02/4/202422:00GLOBERoivant Announces Positive NEPTUNE Study Results for..
13/2/202423:00GLOBERoivant Reports Financial Results for the Third Quarter..
31/1/202408:05GLOBERoivant to Report Financial Results for the Third Quarter..
21/12/202308:30GLOBERoivant Reports Positive Initial Phase 2 Results for..
15/12/202301:00GLOBERoche Completes Acquisition of Telavant from Roivant,..
28/11/202323:00GLOBERoivant Announces Positive IMVT-1402 Initial 600 mg MAD..
28/11/202300:00GLOBERoivant and Priovant Announce Results from Phase 2 Study of..
13/11/202323:00GLOBERoivant Reports Financial Results for the Second Quarter..
11/11/202300:00GLOBERoivant Announces Appointment of Mayukh Sukhatme to Its..
31/10/202308:30GLOBERoivant to Report Financial Results for the Second Quarter..
23/10/202316:00GLOBERoche Enters Into a Definitive Agreement to Acquire Telavant..
26/9/202320:00GLOBERoivant Announces Positive Initial IMVT-1402 Phase 1 SAD and..
11/9/202322:00GLOBERoivant Announces Completion of Redemption of its..
18/8/202306:05GLOBERoivant Announces Redemption Fair Market Value in Connection..
14/8/202321:00GLOBERoivant Reports Financial Results for the First Quarter..
04/8/202306:05GLOBERoivant to Report Financial Results for the Quarter Ended..
03/8/202306:05GLOBERoivant Announces Redemption of Outstanding Warrants
27/7/202322:00GLOBETelavant, a Roivant Company, Advances Inflammatory Bowel..
11/7/202322:00GLOBERoivant Ranks No. 25 on Fast Company’s Fifth Annual List of..
28/6/202322:57GLOBEUPDATE -- Roivant Reports Financial Results for the Fourth..
28/6/202321:00GLOBERoivant Reports Financial Results for the Fourth Quarter and..
27/6/202306:05GLOBERoivant to Report Financial Results for the Fourth Quarter..
22/6/202321:30GLOBERoivant Reports Chronic Period Data for RVT-3101 from the..
22/6/202307:00GLOBERoivant to Host Investor Call at 8:00 AM ET on Thursday,..
16/5/202321:00GLOBERoivant Reports Positive Topline Results from ADORING 1, the..

Your Recent History

NASDAQ
ROIVW
Roivant Sciences
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved